Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wakako Yuji

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The New England Journal of Medicine|April 11, 2025
A Comparison of Peripherally Inserted Central Catheter MaterialsKoichiro Yuji, Wakako Yuji
JAMA Oncology|April 23, 2026
Reassessing Treatment Outcomes Following Immune-Related Adverse EventsKoichiro Yuji, Wakako Yuji
Clinical Chemistry and Laboratory Medicine|July 5, 2026
Artificial general intelligence and the clinical laboratory: a paradigm shift toward Lab 2.0Koichiro Yuji, Wakako Yuji
The New England Journal of Medicine|October 1, 2025
Nerandomilast in Patients with Pulmonary FibrosisKoichiro Yuji, Wakako Yuji
JAMA Oncology|April 9, 2026
Challenges in Interpreting MELATORCH Trial OutcomesKoichiro Yuji, Wakako Yuji
Cerebrovascular Diseases (Basel, Switzerland)|July 4, 2026
Alcohol interaction and ALDH2: missing links in EMPHASISKoichiro Yuji, Wakako Yuji
International Journal of Clinical Pharmacology and Therapeutics|August 27, 2015
Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adultsYuji Kumagai, Yuji Murakawa, Tomoko Hasunuma, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The New England Journal of Medicine|April 11, 2025
A Comparison of Peripherally Inserted Central Catheter MaterialsKoichiro Yuji, Wakako Yuji
JAMA Oncology|April 23, 2026
Reassessing Treatment Outcomes Following Immune-Related Adverse EventsKoichiro Yuji, Wakako Yuji
Clinical Chemistry and Laboratory Medicine|July 5, 2026
Artificial general intelligence and the clinical laboratory: a paradigm shift toward Lab 2.0Koichiro Yuji, Wakako Yuji
The New England Journal of Medicine|October 1, 2025
Nerandomilast in Patients with Pulmonary FibrosisKoichiro Yuji, Wakako Yuji
JAMA Oncology|April 9, 2026
Challenges in Interpreting MELATORCH Trial OutcomesKoichiro Yuji, Wakako Yuji
Cerebrovascular Diseases (Basel, Switzerland)|July 4, 2026
Alcohol interaction and ALDH2: missing links in EMPHASISKoichiro Yuji, Wakako Yuji
International Journal of Clinical Pharmacology and Therapeutics|August 27, 2015
Lack of effect of favipiravir, a novel antiviral agent, on QT interval in healthy Japanese adultsYuji Kumagai, Yuji Murakawa, Tomoko Hasunuma, et al.
Pageof 1